0.4799
Schlusskurs vom Vortag:
$0.48
Offen:
$0.4749
24-Stunden-Volumen:
241.54K
Relative Volume:
0.48
Marktkapitalisierung:
$25.62M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-151.16M
KGV:
-0.1616
EPS:
-2.97
Netto-Cashflow:
$-130.08M
1W Leistung:
+2.87%
1M Leistung:
-0.85%
6M Leistung:
-73.34%
1J Leistung:
-92.87%
Alx Oncology Holdings Inc Stock (ALXO) Company Profile
Firmenname
Alx Oncology Holdings Inc
Sektor
Branche
Telefon
650-466-7125
Adresse
323 ALLERTON AVENUE, SOUTH SAN FRANCISCO
Vergleichen Sie ALXO mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
ALXO
Alx Oncology Holdings Inc
|
0.4799 | 24.93M | 0 | -151.16M | -130.08M | -2.97 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Alx Oncology Holdings Inc Stock (ALXO) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-03-06 | Hochstufung | Jefferies | Hold → Buy |
2024-12-19 | Herabstufung | Jefferies | Buy → Hold |
2024-03-08 | Herabstufung | Stifel | Buy → Hold |
2023-12-08 | Hochstufung | Jefferies | Hold → Buy |
2021-12-22 | Herabstufung | Jefferies | Buy → Hold |
2021-09-30 | Eingeleitet | Stifel | Buy |
2021-05-05 | Fortgesetzt | Credit Suisse | Outperform |
2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
2021-04-06 | Eingeleitet | UBS | Buy |
2021-02-10 | Eingeleitet | H.C. Wainwright | Buy |
2020-08-11 | Eingeleitet | Cantor Fitzgerald | Overweight |
2020-08-11 | Eingeleitet | Credit Suisse | Outperform |
2020-08-11 | Eingeleitet | Jefferies | Buy |
2020-08-11 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Alx Oncology Holdings Inc Aktie (ALXO) Neueste Nachrichten
ALX Oncology Holdings Inc. Stock Analysis and ForecastFree Stock Market Forecast Reports - jammulinksnews.com
Is ALX Oncology Holdings Inc. a good long term investmentMarket-beating returns - jammulinksnews.com
What analysts say about ALX Oncology Holdings Inc. stockFree Predictions - jammulinksnews.com
What drives ALX Oncology Holdings Inc. stock priceFree Wealth Management Insights - Autocar Professional
Will ALX Oncology Holdings Inc. stock benefit from interest rate changesConsistent Win Signals - Newser
How ALX Oncology Holdings Inc. stock performs during market volatilitySwing Trade Signals - Newser
What makes ALX Oncology Holdings Inc. stock price move sharplyRisk Adjusted Stock Signals - Newser
Why ALX Oncology Holdings Inc. stock attracts strong analyst attentionPredictable High Return Trades - Newser
ALX Oncology (NASDAQ:ALXO) Trading Down 3.5% – What’s Next? - Defense World
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Given Average Rating of “Moderate Buy” by Analysts - Defense World
ALX Oncology Confirms Directors at Annual Meeting - TipRanks
ALX Oncology reports annual meeting results By Investing.com - Investing.com Nigeria
ALX Oncology reports annual meeting results - Investing.com
Cantor Fitzgerald Weighs in on ALX Oncology FY2026 Earnings - Defense World
ALX Oncology (NASDAQ:ALXO) Downgraded to “Sell” Rating by Wall Street Zen - Defense World
Nuveen Asset Management LLC Has $275,000 Holdings in ALX Oncology Holdings Inc. (NASDAQ:ALXO) - Defense World
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Shares Acquired by Two Sigma Investments LP - Defense World
Bank of America Corp DE Grows Position in ALX Oncology Holdings Inc. (NASDAQ:ALXO) - Defense World
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Shares Acquired by Deutsche Bank AG - Defense World
Northern Trust Corp Acquires 23,324 Shares of ALX Oncology Holdings Inc. (NASDAQ:ALXO) - Defense World
ALX Oncology to Present at the Jefferies 2025 Global Healthcare Conference - GlobeNewswire
ALX Oncology to Present at the Jefferies 2025 Global Healthcare Conference | ALXO Stock News - GuruFocus
ALX Oncology Management to Showcase Novel Cancer Treatment Advances at Major Jefferies Healthcare Conference - Stock Titan
D. E. Shaw & Co. Inc. Decreases Stock Position in ALX Oncology Holdings Inc. (NASDAQ:ALXO) - Defense World
H.C. Wainwright maintains ALX Oncology stock Buy rating By Investing.com - Investing.com India
H.C. Wainwright maintains ALX Oncology stock Buy rating - Investing.com
Analysts Offer Insights on Healthcare Companies: Tvardi Therapeutics (TVRD) and ALX Oncology Holdings (ALXO) - The Globe and Mail
UBS Group Issues Pessimistic Forecast for ALX Oncology (NASDAQ:ALXO) Stock Price - Defense World
Pre-market Movers: VIGL, CVM, KDLY, VTAK... - RTTNews
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
ALXO: UBS Maintains 'Buy' Rating, Lowers Price Target | ALXO Sto - GuruFocus
ALXO: UBS Maintains 'Buy' Rating, Lowers Price Target | ALXO Stock News - GuruFocus
UBS Adjusts Price Target on ALX Oncology Holdings to $1 From $1.20, Maintains Buy Rating - marketscreener.com
ALX Oncology presents preclinical data, plans for ALX-2004 - BioWorld MedTech
UBS Adjusts Price Target for ALX Oncology (ALXO) to $1 | ALXO St - GuruFocus
Finanzdaten der Alx Oncology Holdings Inc-Aktie (ALXO)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):